Cardiovascular diseases (CVDs) are often perceived as a male-dominated<\/strong> health issue. However, this misconception undermines the significant impact these conditions have on women’s health globally. It’s crucial to recognize<\/strong> that CVD is the leading cause of death among women, accounting for over eight million<\/strong> deaths each year worldwide. This issue demands urgent attention, especially considering that women have unique risk factors and experiences that are often overlooked.<\/p>\n Every year, millions of women die due to CVDs, given that cardiovascular issues are responsible for nearly half of female mortality<\/strong>. Surprisingly, a woman’s likelihood<\/strong> of dying from a heart attack is four times greater than her risk of succumbing to breast cancer. Shockingly, there has been a 25% increase<\/strong> in heart attack cases among premenopausal women in the last decade. This startling trend highlights the urgent need for better awareness and understanding of cardiovascular health in women.<\/p>\n One of the primary reasons for the lack of effective treatment lies in misdiagnosis<\/strong>. Heart attacks are often labeled as "male diseases," causing many healthcare professionals to dismiss signs when they appear in women. Research indicates that when a woman experiences a heart attack, she tends to call for help approximately thirty minutes later<\/strong> than her male counterparts. Emergency medical responders may also be less likely to associate her symptoms with a heart attack, particularly if she is younger and non-menopausal.<\/p>\n For years, the medical community perpetuated the belief that women experience different symptoms during a heart attack. This is largely inaccurate<\/strong>; the reality is that over 90%<\/strong> of women report experiencing chest pain, similar to men. The problem lies in social conditioning. Women are often trained to dismiss their pain, viewing it as a normal part of life, which can lead to catastrophic consequences.<\/p>\n Women experience specific risk factors that contribute to their vulnerability to CVDs. Conditions like endometriosis<\/strong>, menopause<\/strong>, and polycystic ovary syndrome<\/strong> are critical yet frequently ignored. Furthermore, complications from pregnancy, such as gestational hypertension<\/strong> and preeclampsia<\/strong>, also substantially increase long-term risks of heart disease. These factors require heightened vigilance from healthcare providers and better education for women about their health.<\/p>\n Historically, women have been underrepresented in clinical trials, resulting in treatment protocols that are largely based on male physiology. The consequences are severe: treating women as medical "exceptions" often leads to delays in appropriate care, affecting their overall health outcomes.<\/p>\n Despite the overwhelming evidence, disparities in treatment persist. Cardiovascular care continues to be primarily designed for men, with protocols<\/strong> and medications tested on male subjects. Women are more likely to suffer from side effects<\/strong>, which often leads them to discontinue treatment. After experiencing a heart attack, women are also less likely to participate in cardiac rehabilitation programs, which are essential for recovery.<\/p>\n The existing healthcare framework rarely accounts for the unique circumstances women face, such as mental load<\/strong>, childcare responsibilities, and fragmented schedules. This lack of accommodation creates barriers that prevent women from accessing critical health services. Many rehabilitation programs do not consider these realities, leaving women in a vulnerable position.<\/p>\n The roots of this gender bias can be traced back to the 1960s<\/strong>, when women were systematically excluded from clinical studies to avoid risks associated with pregnancy. This approach has led to a medical landscape primarily designed for men, disregarding the complexities of female physiology. As a result, hormonal differences have often been treated as variables to be eliminated rather than factors to be studied comprehensively.<\/p>\n To bridge these gaps, healthcare systems must adapt to recognize and address the unique health challenges faced by women. It’s essential to include more women in clinical trials and actively promote education regarding women’s cardiovascular health. By doing so, healthcare providers can ensure more accurate diagnoses<\/strong> and effectively manage treatment plans tailored to the needs of female patients.<\/p>\n The ongoing crisis surrounding cardiovascular diseases in women necessitates immediate action. Increasing awareness, improving diagnostic protocols, and addressing unique risk factors are essential steps towards averting this overlooked health epidemic. Understanding that cardiovascular diseases are not just "male diseases" but a serious health concern for women is the first step in changing societal perceptions.<\/p>\n Plus de huit millions : c\u2019est le nombre de d\u00e9c\u00e8s dans le monde chaque ann\u00e9e li\u00e9s aux maladies cardiovasculaires<\/a> parmi les femmes, selon l\u2019OMS<\/a>. <\/span>Responsable de pr\u00e8s de la moiti\u00e9 de la mortalit\u00e9 f\u00e9minine, en France, <\/span>une femme<\/a> a quatre fois plus de risques de mourir d\u2019un infarctus que d\u2019un cancer du sein<\/a>. Ces maladies, premi\u00e8re cause de d\u00e9c\u00e8s chez les femmes, sont pourtant encore per\u00e7ues comme masculines, alors qu\u2019elles repr\u00e9sentent la deuxi\u00e8me cause de mortalit\u00e9 chez les hommes, avec 40 %. Et chez les femmes jeunes non m\u00e9nopaus\u00e9es, les cas ont augment\u00e9 de 25 % en dix ans.<\/p>\n \u00c0 l\u2019occasion de la Journ\u00e9e internationale d\u2019action pour la sant\u00e9 des femmes ce 28 mai, 20 Minutes<\/span> interroge Martine Gilard, professeure de cardiologie<\/a>, pr\u00e9sident de l\u2019association europ\u00e9enne de cardiologie et administratrice de la Fondation Coeur et Recherche.<\/p>\n<\/div>\nThe Alarming Statistics<\/h2>\n
Misdiagnosis and Delayed Response<\/h2>\n
Different Symptoms, Same Pain<\/h3>\n
Unique Risk Factors in Women<\/h2>\n
Clinical Trial Representation<\/h3>\n
Continuing Disparities in Treatment<\/h2>\n
The Social Factor: A Major Barrier<\/h3>\n
Historical Roots of Gender Bias<\/h2>\n
The Urgent Need for Change<\/h3>\n
Conclusion<\/h2>\n